HAE — Haemonetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Haemonetics, fiscal year end - April 1st, USD millions except per share, conversion factor applied.

	2019 March 30th	2020 March 28th	2021 April 3rd	2022 April 2nd	2023 April 1st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	169	137	192	259	284
Net Total Accounts Receivable
Net Total Receivables	185	165	128	159	179
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	576	604	694	756	770
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	344	306	277	311	364
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,275	1,267	1,820	1,860	1,935
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	236	275	253	442	252
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	607	680	1,088	1,110	1,117
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	668	587	732	749	818
Total Liabilities & Shareholders' Equity	1,275	1,267	1,820	1,860	1,935
Total Common Shares Outstanding